全文获取类型
收费全文 | 560篇 |
免费 | 0篇 |
专业分类
电工技术 | 1篇 |
化学工业 | 18篇 |
金属工艺 | 3篇 |
机械仪表 | 3篇 |
建筑科学 | 4篇 |
能源动力 | 9篇 |
轻工业 | 5篇 |
水利工程 | 14篇 |
石油天然气 | 52篇 |
无线电 | 5篇 |
一般工业技术 | 26篇 |
冶金工业 | 414篇 |
自动化技术 | 6篇 |
出版年
2021年 | 2篇 |
2017年 | 2篇 |
2016年 | 3篇 |
2014年 | 2篇 |
2013年 | 5篇 |
2012年 | 3篇 |
2011年 | 7篇 |
2010年 | 2篇 |
2009年 | 7篇 |
2008年 | 6篇 |
2007年 | 7篇 |
2006年 | 2篇 |
2005年 | 4篇 |
2004年 | 2篇 |
2003年 | 2篇 |
2002年 | 4篇 |
2000年 | 4篇 |
1999年 | 9篇 |
1998年 | 104篇 |
1997年 | 58篇 |
1996年 | 40篇 |
1995年 | 27篇 |
1994年 | 33篇 |
1993年 | 27篇 |
1992年 | 5篇 |
1991年 | 10篇 |
1990年 | 17篇 |
1989年 | 9篇 |
1988年 | 6篇 |
1987年 | 11篇 |
1986年 | 6篇 |
1985年 | 10篇 |
1984年 | 4篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 5篇 |
1980年 | 8篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 26篇 |
1976年 | 40篇 |
1975年 | 5篇 |
1974年 | 3篇 |
1973年 | 2篇 |
1972年 | 2篇 |
1971年 | 6篇 |
1970年 | 2篇 |
1969年 | 2篇 |
1968年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有560条查询结果,搜索用时 15 毫秒
1.
NF Saba JD Sweeney LC Penn JC Lawton RL Yankee CH Huang MS Schanfield 《Canadian Metallurgical Quarterly》1997,37(3):321-324
PURPOSE: We report a case of postoperative reparalysis in the recovery room, following nebulized epinephrine. The patient was pharmacologically reversed with edrophonium after paralysis with rocuronium. CLINICAL FINDINGS: A 12-yr-old girl developed postoperative reparalysis following the intraoperative administration of rocuronium. A total of 0.92 mg.kg-1 rocuronium was administered. After surgery, pharmacological reversal was achieved with 20 mg edrophonium with 0.15 mg atropine sulfate iv 35 min after the last administration of rocuronium. Muscular relaxation was monitored using an ulnar peripheral nerve stimulator (PNS). After reversal, a full train-of-four and sustained tetanus at 50 Hz were present. In the recovery room, following nebulized epinephrine, the patient became apneic. The patient was paralyzed and an ulnar PNS demonstrated only one faint twitch. The paralysis was reversed with 1.5 mg neostigmine with 0.3 mg glycopyrrolate. CONCLUSION: Postoperative reparalysis following rocuronium may be a cause of postoperative respiratory distress. The definitive diagnosis is made using PNS and observing the response to pharmacological reversal. Nebulized epinephrine may have a previously undescribed role in the development of postoperative reparalysis. 相似文献
2.
3.
A. Kh. Abduev A. Sh. Asvarov A. K. Akhmedov V. G. Baryshnikov E. I. Terukov 《Technical Physics Letters》2002,28(11):952-954
We observed zinc oxide structures formed in an oxygen-containing atmosphere as a result of oxidation of the surface of zinc droplets. The gas-phase oxidation leads to the formation of hollow ZnO whiskers on the metal surface, which grow due to the transport of zinc vapor through their channels. It was found that high partial pressures of zinc and atomic oxygen give rise to fractal structures, which appear in a cascade process involving the sequential formation of zinc oxide vapor, ZnO clusters, and cluster aggregates as a result of the cluster-cluster interaction. A deposit of ZnO synthesized on the cathode surface exhibits a columnar structure. 相似文献
4.
FF Fassos J Klein D Fernandes D Matsui NF Olivieri G Koren 《Canadian Metallurgical Quarterly》1996,34(7):288-292
Recently, we demonstrated that administration of the orally active iron chelating agent deferiprone (1,2-dimethyl-3-hydroxypyrid-4-one (L1)) at 6-hour intervals results in significantly greater urinary iron excretion than that induced during administration of the drug at 12-hour intervals. That study was conducted in thalassemia patients, all of whom had received a packed red cell transfusion of 15 cc/kg. 72 hours prior to evaluation of urinary iron excretion, at a time when endogenous erythropoiesis would be expected to be at its lowest. In clinical practice however, thalassemia patients, suppression of endogenous erythropoiesis is not sustained between transfusions. We set out to determine the influence that administration of deferiprone has on urinary iron excretion at lower hemoglobin concentrations, immediately prior to transfusion. We hypothesized that hemoglobin levels will affect the ability of deferiprone to chelate iron. Ten regularly transfused patients with homozygous beta-thalassemia (HBT) aged mean +/- SD, 20.9 +/- 4.7, range 13 - 27 years, receiving long-term therapy with deferiprone, were treated with deferiprone 75 mg/kg/day, administered every 6 hours (or every 12 hours) for 72 hours immediately prior to a blood transfusion in the first month. One month later each patient received the other of the 2 dosing regimens for 72 hours immediately prior to transfusion. The deferiprone-induced 24-hour urinary iron excretion was similar during both dosing regimens; 0.56 +/- 0.45 mg/kg when L1 was given every 6 hours and 0.48 +/- 0.52 mg/kg when L1 was administered every 12 hours (p = 0.79). However, the calculated 24-hour area under the plasma concentration-time curve (AUC0-24) of deferiprone was significantly lower when deferiprone was administered at 6-hour intervals (6,762.8 +/- 1,601.6 mg*min/l), than that observed when deferiprone was administered every 12 hours (8,250.1 +/- 1,235.7 mg*min/l) (p = 0.04). The pharmacokinetics of deferiprone when administered immediately prior to transfusions are different from those following transfusions. More studies assessing total body iron excretion are needed to determine the contribution of the fecal route in iron excretion. 相似文献
5.
6.
Ch. M. Gadzhiev M. M. Isaev T. G. Akhmedov R. A. Sadykhov T. M. Mirzoev 《Measurement Techniques》1996,39(6):629-632
We propose a technique for optimal selection of standard pressure controllers for obtaining the best calibration characteristics
for differential pressure gauges, ensuring high-quality metrological characteristics for the data acquisition systems for
determination of the mass of petroleum products in storage tanks.
Translated from Izmeritel'naya Tekhnika, No. 6, pp. 36–38, June, 1996. 相似文献
7.
8.
JU Weaver L Thaventhiran K Noonan JM Burrin NF Taylor MR Norman JP Monson 《Canadian Metallurgical Quarterly》1994,41(5):639-648
OBJECTIVE: Growth hormone (GH) replacement therapy in hypopituitary adults is associated with sodium and water retention. The underlying mechanisms are incompletely understood and a possible contribution of altered cortisol metabolism or action has not been evaluated. We have investigated the effect of GH replacement therapy on cortisol metabolism, cortisol binding globulin and in-vitro glucocorticoid sensitivity in a group of adult hypopituitary patients. DESIGN AND PATIENTS: We studied 19 adult hypopituitary patients (18 adult onset, M:F, 6:13), who were receiving conventional hydrocortisone (16 patients), thyroxine (14 patients), triiodothyronine (1 patient), sex steroid (9 patients), human chorionic gonadotrophin (1 patient) or desmopressin (6 patients) replacement during a 6-month, double blind controlled trial of GH therapy (active:placebo, 8:11) followed by a 6-month open phase of GH (mean dose: 0.2 IU/kg/week, range 0.051-0.27) and after a 6-week washout phase following discontinuation of GH therapy. MEASUREMENTS: Twenty-four-hour urine free cortisol, cortisol metabolites (CoM), ratio 11-hydroxy/11-oxo CoM (F/E) and ratio 5 alpha/beta tetrahydrocortisol were measured at 6 months, 12 months and after the 6 week washout phase. Serum cortisol binding globulin was measured basally, at 6 months, 12 months and after washout. Glucocorticoid sensitivity was determined in lymphocyte preparations from 8 patients, during GH therapy and after washout, using an in-vitro technique dependent on dexamethasone suppression of phytohaemagglutinin-stimulated thymidine incorporation into DNA. Plasma renin activity and aldosterone were measured after 6-12 months GH therapy and after washout. RESULTS: After 6 months of GH, in patients on hydrocortisone (n = 9), there were significant decreases in CoM (mean decrement 21%, P < 0.01), F/E (mean decreased from 1.27 to 1.0, P = 0.04; reference range 0.33-1.29) and 5 alpha/5 beta tetrahydrocortisol (mean decreased from 0.67 to 0.48, P = 0.01) and a subsequent increase after washout. Patients not on hydrocortisone (n = 2) demonstrated a normal basal F/E falling by 25% on GH therapy but no change in CoM. During 12 months of GH therapy, patients on hydrocortisone (n = 7) demonstrated a further trend to decrement in CoM (P = 0.09) which reversed after washout (P = 0.04). Urine free cortisol tended to fall during GH therapy and increased significantly following washout after 12 months treatment (P < 0.02). Serum cortisol binding globulin decreased by 20% (P < 0.05) during 12 months GH treatment but remained within the reference range. In-vitro studies demonstrated a trend to reduced glucocorticoid sensitivity on GH therapy; the maximum inhibition of phytohaemagglutinin by dexamethasone tended to be less on GH therapy (P = 0.052) and was also lower than in 29 normal volunteers (P < 0.05). There were no significant changes in plasma renin but there was a small increment in aldosterone in recumbent patients (P = 0.04) during the open phase of GH therapy in the placebo arm. CONCLUSIONS: GH therapy in hypopituitary adults is associated with an apparent reduction in availability of administered hydrocortisone as measured by urine cortisol metabolites and urine free cortisol. This effect is unlikely to be clinically significant except possibly in ACTH deficient subjects on suboptimal hydrocortisone replacement. The changes in F/E suggest that GH may directly or indirectly modulate the activity of 11 beta-hydroxysteroid dehydrogenase. The apparent decrease in glucocorticoid sensitivity during GH therapy, demonstrated in vitro, merits further investigation. 相似文献
9.
G. V. Chucheva A. G. Zhdan G. A. Akhmedov N. F. Kukharskaya 《Instruments and Experimental Techniques》2005,48(4):498-502
A metal-oxide-semiconductor (MOS) structure with the common field electrode insulated from the semiconductor by oxide layers h of different thicknesses allows the surface generation rate of minority charge carriers from current I(t) of nonequilibrium depletion state relaxation to be found. At the same time, it is possible in similar structures to observe the kinematics of electron-hole pair generation at the periphery of the field electrode (the edge generation effect). Measurements performed on an n-Si MOS structure with a stepwise change in oxide layer thickness (h
1 = 100 Å and h
2 = 3200 Å) allowed the generation rate at both the initial transient (t ∼ 10−5 s) stage of surface generation (4.34 × 1010 cm−2 s−1) and at the basic extremely slow stage (10.4 cm−2 s−1) to be reliably determined for the first time. The estimated peripheral generation rate of minority charge carriers (holes) was 7.8 × 1011 cm−2 s−1.__________Translated from Pribory i Tekhnika Eksperimenta, No. 4, 2005, pp. 84–88.Original Russian Text Copyright © 2005 by Chucheva, Zhdan, Akhmedov, Kukharskaya. 相似文献
10.
A. F. Akhmedov 《Chemistry and Technology of Fuels and Oils》2002,38(3):184-187
The results of studies of oligomerization of C6 —olefins in the presence of aluminum chloride and different alkyl-, alkenylaromatic, and carbocyclic compounds are generalized. By altering the conditions of oligomerization and the nature of the C6 —olefin hydrocarbons, viscosity additives and petroleum oil components, as well as synthetic base oils and feedstock for polyfunctional additives can be manufactured. The oligomerization conditions are a function of the concrete requirements for the quality of the synthesized compounds. 相似文献